← Back to Search
Nanosphere-mediated Delivery Of Vascular Endothelial Growth Factor Gene For Therapeutic Angiogenesis In Mouse Ischemic Limbs
Sun-Woong Kang, Hee-Won Lim, Sang-Woo Seo, O. Jeon, Minhyung Lee, B. Kim
Published 2008 · Materials Science
Download PDFAnalyze on Scholarcy
Polymeric nanosphere-mediated gene delivery may sustain the duration of plasmid DNA (pDNA) administration. In this study, poly(lactic-co-glycolic acid) (PLGA) nanospheres were evaluated as a gene carrier. The pDNA-loaded PLGA nanospheres were formulated with high encapsulation efficiency (87%). The nanospheres sustained release of pDNA for 11 days. The released pDNA maintained its structural and functional integrity. Furthermore, the PLGA nanospheres showed lower cytotoxicity than polyethylenimine (PEI) in vitro and in vivo. The nanospheres with vascular endothelial growth factor (VEGF) gene were injected into skeletal muscle of ischemic limb model, and gene expression mediated by the PLGA nanospheres with VEGF gene was compared to that of PEI/pDNA or naked pDNA in vivo. PLGA nanosphere/pDNA had significantly higher VEGF expression levels in comparison to PEI/pDNA and naked pDNA at 12 days after administration. In addition, gene therapy using PLGA nanospheres resulted in more extensive neovascularization at ischemic sites than both naked pDNA and PEI/pDNA. These results indicated that PLGA nanosphere might be useful as a potential carrier for skeletal muscle gene delivery applications.
This paper references
Sustained delivery and expression of DNA encapsulated in polymeric nanoparticles
H. Cohen (2000)
Poly(l-lactide-co-glycolide) nanospheres conjugated with a nuclear localization signal for delivery of plasmid DNA
O. Jeon (2007)
Poly (D, L-lactide-co-glycolide)/DNA microspheres to facilitate prolonged transgene expression in airway epithelium in vitro, ex vivo and in vivo
M. Stern (2003)
Recent advances in liposome technologies and their applications for systemic gene delivery.
Microspheres containing plasmid-encoded antigens elicit cytotoxic T-cell responses
M. L. Hedley (1998)
Biologically erodable microspheres as potential oral drug delivery systems
E. Mathiowitz (1997)
Folate-PEG-Folate-Graft-Polyethylenimine-Based Gene Delivery
J. M. Benns (2001)
A powerful nonviral vector for in vivo gene transfer into the adult mammalian brain: polyethylenimine.
B. Abdallah (1996)
Pharmacological regulation of protein expression from adeno-associated viral vectors in the eye.
A. Auricchio (2002)
Gene therapy for tissue repair and regeneration.
Toward development of a non-viral gene therapeutic.
Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease.
M. Cavazzana-Calvo (2000)
A DNA controlled-release coating for gene transfer: transfection in skeletal and cardiac muscle.
V. Labhasetwar (1998)
Deletion of multiple immediate–early genes from herpes simplex virus reduces cytotoxicity and permits long-term gene expression in neurons
DM Krisky (1998)
Recombinant adeno-associated virus type 2, 4, and 5 vectors: transduction of variant cell types and regions in the mammalian central nervous system.
B. Davidson (2000)
Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis.
H. Dvorak (1995)
Hypoxia-inducible VEGF gene delivery to ischemic myocardium using water-soluble lipopolymer
M. Lee (2003)
The manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glycolide) (PLGA) devices.
R. Jain (2000)
Size matters: molecular weight affects the efficiency of poly(ethylenimine) as a gene delivery vehicle.
W. Godbey (1999)
Rapid endo‐lysosomal escape of poly(DL‐lactide‐coglycolide) nanoparticles: implications for drug and gene delivery
J. Panyam (2002)
Synergistic effect of sustained delivery of basic fibroblast growth factor and bone marrow mononuclear cell transplantation on angiogenesis in mouse ischemic limbs.
O. Jeon (2006)
Vascular Endothelial Growth Factor Gene Delivery by Magnetic DNA Nanospheres Ameliorates Limb Ischemia in Rabbits1
H. Jiang (2005)
Long-term and zero-order release of basic fibroblast growth factor from heparin-conjugated poly(L-lactide-co-glycolide) nanospheres and fibrin gel.
O. Jeon (2006)
Biodegradable polyesters for controlled release of trypanocidal drugs: in vitro and in vivo studies.
Y. Lemmouchi (1998)
Gene transfection using biodegradable nanospheres: results in tissue culture and a rat osteotomy model
V. Labhasetwar (1999)
Formulation and characterization of poly (d,l‐lactide‐co‐glycolide) nanoparticle containing vascular endothelial growth factor for gene delivery
F. Yi (2006)
DNA delivery to the mitochondria sites using mitochondrial leader peptide conjugated polyethylenimine
M. Lee (2007)
Cellular interactions and degradation of aliphatic poly(ester amide)s derived from glycine and/or 4-amino butyric acid.
S. Han (2003)
DNA delivery from polymer matrices for tissue engineering
L. Shea (1999)
This paper is referenced by
Examining the biophysics of ultrasound and contrast agent induced angiogenesis
C. Johnson (2011)
1.123 – Degradable Polymers
K.K.L. Phua (2011)
Recent developments of biodegradable and biocompatible materials based micro/nanoparticles for delivering macromolecular therapeutics.
Y. Shi (2009)
Immune responses to polyethylenimine delivered plasmid DNA encoding a Fasciola gigantica fatty acid binding protein in mice and rabbits.
O. K. Raina (2009)
The effect of the controlled release of nerve growth factor from collagen gel on the efficiency of neural cell culture.
S. H. Bhang (2009)
Nonviral delivery of genetic medicine for therapeutic angiogenesis.
H. Park (2012)
Non-viral polyplexes: Scaffold mediated delivery for gene therapy
Suzanne O’Rorke (2010)
Administration of PLGA nanoparticles carrying shRNA against focal adhesion kinase and CD44 results in enhanced antitumor effects against ovarian cancer
L. Zou (2013)
INJECTABLE DELIVERY SYSTEM BASED ON 5-ETHYLENE KETAL-ε - CAPROLACTONE FOR THE DELIVERY OF VEGF AND HGF FOR TREATING CRITICAL LIMB ISCHEMIA
Iyabo Oladunni Babasola (2012)
PROCESS FOR FORMATION OF CATIONIC POLY (LACTIC-CO-GLYCOLIC ACID) NANOPARTICLES USING STATIC MIXERS
Yamuna Reddy Charabudla (2008)
Standardization of models and methods used to assess nanoparticles in cardiovascular applications.
Kathleen T Fitzgerald (2011)
Controlled Release Systems Targeting Angiogenesis
Stéphanie Deshayes (2019)
Developing bone cement implants impregnated with bacteriocins for prevention of infections
Van Staden (2011)
Ionically cross-linked chitosan microspheres for controlled release of bioactive nerve growth factor.
W. Zeng (2011)
Controllable preparation of SB-3CT loaded PLGA microcapsules for traumatic-brain-injury pharmaco-therapy
Hong Chen (2018)
1.24 Degradable Polymers
Kyle K. L. Phua (2017)
A summary on non-viral systems for gene delivery based on natural and synthetic polymers
Raana Sarvari (2020)
9 – Nanotechnology and nanomedicine in cardiovascular therapy
T. Khan (2010)
Genetically engineered angiogenic cell sheets using magnetic force-based gene delivery and tissue fabrication techniques.
Hirokazu Akiyama (2010)
Nanoscale strategies: treatment for peripheral vascular disease and critical limb ischemia.
Chengyi Tu (2015)
Therapeutic angiogenesis of PLGA-heparin nanoparticle in mouse ischemic limb
Li-Shan Lian (2012)
Effective modulation of transforming growth factor-β1 expression through engineered microRNA-based plasmid-loaded nanospheres.
Youlang Zhou (2015)
Biodegradable nanoparticles modified by branched polyethylenimine for plasmid DNA delivery.
Sejin Son (2010)
Ligand-modified gene carriers increased uptake in target cells but reduced DNA release and transfection efficiency.
Yen Cu (2010)
Angiogenic gene-modified fibroblasts for induction of localized angiogenesis.
C. Mueller (2010)
Cell-controlled and spatially arrayed gene delivery from fibrin hydrogels.
P. Lei (2009)
Mapping local pH in live cells using encapsulated fluorescent SERS nanotags.
A. Pallaoro (2010)
Gene-Loaded Nanoparticle-Coated Sutures Provide Effective Gene Delivery to Enhance Tendon Healing.
Y. L. Zhou (2019)
PLGA:poloxamer blend micro- and nanoparticles as controlled release systems for synthetic proangiogenic factors.
Yolanda Parajó (2010)
Stress Conditioning and Heat Shock Protein Manipulation for Bone Tissue Engineering
Eunna Chung (2010)
Local pharmacological induction of angiogenesis: Drugs for cells and cells as drugs.
D. Gaspar (2019)
Controlled and sustained gene delivery from injectable, porous PLGA scaffolds.
O. Jeon (2011)See more